https://dermsquared.com/videos/discourses-in-dermatology/cosibelimab-mechanism-of-action
Understanding the Mechanism of Action of Cosibelimab in Advanced cSCC
Explore the mechanism of action of cosibelimab, a PD-L1 inhibitor approved for the treatment of advanced cutaneous squamous cell carcinoma.
mechanism of actionunderstandingcosibelimabadvancedcscc